Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Expert Review of Anticancer Therapy
|
August 19, 2017
Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
Eva Segelov, Florian Lordick, David Goldstein, et al.
Targeted Oncology
|
November 25, 2021
Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry
Anas Alawawdeh, Cynthia Piantadosi, Amanda Rose Townsend, et al.
Expert Review of Anticancer Therapy
|
February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis
Monica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Targeted Oncology
|
January 20, 2019
Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
Li Chia Chong, Amanda Rose Townsend, Joanne Young, et al.
Pancreas
|
July 18, 2022
Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma
Amitesh Chandra Roy, M Nazim Abbas, Timothy Jay Price, et al.
Clinical Colorectal Cancer
|
May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer
Lisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
BMC Cancer
|
December 19, 2019
SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial
Michael B Jameson, Kirsten Gormly, David Espinoza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer
Marc Peeters, Timothy Jay Price, Andrés Cervantes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Expert Review of Anticancer Therapy
|
August 19, 2017
Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty
Eva Segelov, Florian Lordick, David Goldstein, et al.
Targeted Oncology
|
November 25, 2021
Prognostic Differences of RAS Mutations: Results from the South Australian Metastatic Colorectal Registry
Anas Alawawdeh, Cynthia Piantadosi, Amanda Rose Townsend, et al.
Expert Review of Anticancer Therapy
|
February 27, 2018
Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis
Monica Tang, Timothy Jay Price, Jeremy Shapiro, et al.
Targeted Oncology
|
January 20, 2019
Outcomes for Metastatic Colorectal Cancer Based on Microsatellite Instability: Results from the South Australian Metastatic Colorectal Cancer Registry
Li Chia Chong, Amanda Rose Townsend, Joanne Young, et al.
Pancreas
|
July 18, 2022
Phase I Trial of nab-Paclitaxel Administered Concurrently With Radiotherapy in Patients With Locally Advanced Inoperable Pancreatic Adenocarcinoma
Amitesh Chandra Roy, M Nazim Abbas, Timothy Jay Price, et al.
Clinical Colorectal Cancer
|
May 22, 2026
Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer
Lisa Salvatore, Marwan Fakih, Yasutoshi Kuboki, et al.
BMC Cancer
|
December 19, 2019
SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial
Michael B Jameson, Kirsten Gormly, David Espinoza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 6, 2010
Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients with metastatic colorectal cancer
Marc Peeters, Timothy Jay Price, Andrés Cervantes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 16, 2026
[<sup>177</sup>Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial
David L Chan, Katrin Marie Sjoquist, David Turner Ransom, et al.
Page
of 2